Company: PACB
Filing Date: 2025-03-17
Form Type: 10-K
Source: 0001299130-25-000061
Chunk: 973

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-03-17
Form: 10-K
Item: Item 8
Chunk 973
---
 cash equivalents, and restricted cash at end of period $57,592 $182,633 $328,311 Cash and cash equivalents at end of period 55,370 179,911 325,089 Restricted cash at end of period 2,222 2,722 3,222 Cash, cash equivalents, and restricted cash at end of period $57,592 $182,633 $328,311  Supplemental disclosure of cash flow informationInterest paid$14,805 $15,687 $14,049 Supplemental disclosure of non-cash investing and financing activitiesInventory transferred to property and equipment $4,194 $3,984 $2,812 Property and equipment transferred to inventory$(2,572)$(7,022)$(715)Right-of-use asset and liability additions and modifications$18,253 $— $— Issuance of common stock in conjunction with convertible notes exchange$36,199 $— $— Issuance of common stock in acquisition of Apton and Omniome$— $76,642 $— Issuance of common stock in connection with Apton liquidity event bonus plan$— $2,111 $— Convertible notes exchange$— $441,000 $— Issuance of common stock following milestone achievement$— $84,761 $—     

See accompanying notes to the consolidated financial statements.

Fiscal 2024 Form 10-K89